RxSight Inc (RXST) USD0.001

Sell:$6.80Buy:$7.20Price decreased$0.26 (3.70%)

Prices delayed by at least 15 minutes
Sell:$6.80
Buy:$7.20
Change:Price decreased$0.26 (3.70%)
Prices delayed by at least 15 minutes
Sell:$6.80
Buy:$7.20
Change:Price decreased$0.26 (3.70%)
Prices delayed by at least 15 minutes

Company Information

About this company

RxSight, Inc. is a commercial-stage medical technology company engaged in providing customized vision to patients following cataract surgery. Its RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system is composed of RxSight Light Adjustable Lens (LAL), RxSight Light Delivery Device (LDD) and related accessories. The LAL is an intraocular lens (IOL) made from the silicone-based photosensitive material that undergoes controlled changes in refractive power when exposed to specific ultraviolet (UV) light patterns generated by the LDD. Its LAL uses a silicone formulation that enables changing the mechanical and optical properties of the lens following implantation. The LDD uses software and algorithms to deliver a short UV light exposure treatment that polymerizes specific portions of the lens and allows doctors to adjust spherical and cylindrical refraction.

Key people

J. Andy Corley
Independent Chairman of the Board
Tamara R. Fountain
Independent Director
Ron M. Kurtz
President, Chief Executive Officer, Director
Ilya Goldshleger
Co-President, Chief Operating Officer
Eric Weinberg
Co-President, Chief Business Development Officer
Mark A. Wilterding
Chief Financial Officer
Scott Gaines
Chief Customer Officer
Julie B. Andrews
Independent Director
Juliet Tammenoms Bakker
Independent Director
Raymond Wayne Cohen
Independent Director
Click to see more

Key facts

  • Shares in issue
    41.27m
  • EPIC
    RXST
  • ISIN
    US78349D1072
  • Location
    United States
  • Sector
    Capital Goods
  • Industry
    Misc. Capital Goods
  • Market cap
    $274.01m
  • Employees
    461
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.